KRYS - Krystal Biotech Inc Stock Price, Fair Value and News

$217.64+2.58 (+1.20%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

KRYS Price Action

Last 7 days

-0.5%

Last 30 days

10%

Last 90 days

45.3%

Trailing 12 Months

17.0%

KRYS RSI Chart

KRYS Valuation

Market Cap

6.3B

Price/Earnings (Trailing)

31.73

Price/Sales (Trailing)

16.91

EV/EBITDA

30.76

Price/Free Cashflow

38.11

KRYS Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

KRYS Fundamentals

KRYS Revenue

Revenue (TTM)

373.2M

Rev. Growth (Yr)

16.65%

Rev. Growth (Qtr)

1.83%

KRYS Earnings

Earnings (TTM)

198.9M

Earnings Growth (Yr)

192%

Earnings Growth (Qtr)

107.04%

KRYS Profitability

EBT Margin

50.10%

Return on Equity

17.48%

Return on Assets

16.04%

Free Cashflow Yield

2.62%

KRYS Investor Care

Shares Dilution (1Y)

0.82%

Diluted EPS (TTM)

6.68

KRYS Alerts

Big jump in Earnings (Y/Y)

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	333.4M	359.2M	373.2M	0
2024	108.5M	166.2M	241.5M	290.5M
2023	0	0	0	50.7M
2018	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

About Krystal Biotech Inc

Krystal Biotech, Inc., a biotechnology company, develops and commercializes genetic medicines for patients with rare diseases in the United States. It develops beremagene geperpavec (B-VEC) for dystrophic epidermolysis bullosa; KB105 for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for netherton syndrome; and KB407 for Cystic Fibrosis. The company also develops KB408 for Alpha-1 antitrypsin deficiency; and KB301 for aesthetic skin conditions. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

CEO	Mr. Krish S. Krishnan M.B.A., M.S.
WEBSITE	krystalbio.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	210

Krystal Biotech Inc Frequently Asked Questions

What is the ticker symbol for Krystal Biotech Inc? What does KRYS stand for in stocks?

KRYS is the stock ticker symbol of Krystal Biotech Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Krystal Biotech Inc (KRYS)?

As of Wed Dec 03 2025, market cap of Krystal Biotech Inc is 6.31 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of KRYS stock?

You can check KRYS's fair value in chart for subscribers.

Is Krystal Biotech Inc a good stock to buy?

The fair value guage provides a quick view whether KRYS is over valued or under valued. Whether Krystal Biotech Inc is cheap or expensive depends on the assumptions which impact Krystal Biotech Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for KRYS.

What is Krystal Biotech Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, KRYS's PE ratio (Price to Earnings) is 31.73 and Price to Sales (PS) ratio is 16.91. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. KRYS PE ratio will change depending on the future growth rate expectations of investors.